Mymetics Corp MYMX:OTCQB

RT Quote | Exchange | USD
Last | 02/25/21 EST
0.1298UNCH (UNCH)
52 week range
0.02 - 0.19

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.1298
  • 52 Week High0.19
  • 52 Week High Date02/11/21
  • 52 Week Low0.02
  • 52 Week Low Date05/08/20
  • Market Cap39.43M
  • Shares Out303.76M
  • 10 Day Average Volume0.00M
  • Dividend-
  • Dividend Yield-
  • Beta0.16
  • 1 Year % Change308.18

RATIOS/PROFITABILITY

  • EPS (TTM)-0.02
  • P/E (TTM)-8.18
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-1.875M
  • ROE (MRQ)-
  • Revenue (MRQ)870,000.00
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-578.09%
  • Debt To Equity (MRQ)-101.66%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Mymetics Corp News

There is no recent news for this security.

Latest MYMX News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and...
Ronald Kempers
President
Address
European Executive Ofc
route de la Corniche 4
Epalinges
1066
Switzerland